ARCHIMED /
Standard BioTools’ Microfluidics Business
ARCHIMED completes purchase of Standard BioTools’ Microfluidics Business
- Terms
- Not stated
- Stage
- Closed
What happened
ARCHIMED completed its acquisition of Standard BioTools’ Microfluidics Business on Nov. 3, 2026. The business will operate as Biomark Scientific.
Biomark Scientific will provide genomic workflows powered by proprietary microfluidics technology.
Who bought Standard BioTools’ Microfluidics Business?
ARCHIMED acquired Standard BioTools’ Microfluidics Business (Closed, published 3 Nov 2026).
The source
Everything on this page comes from the source below.
ARCHIMED completes purchase of Standard BioTools’ Microfluidics Business
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Closed
The source this page is built from.
Published by the source
The source this page is built from.
The same firms, in other posted deals
- ARCHIMED · buyer · ArchiMed / NatusBefore this deal
- ARCHIMED · buyer · ARCHIMED / ZimVieBefore this deal
- ARCHIMED · buyer · ARCHIMED / GeneticaBefore this deal
- ARCHIMED · buyer · ARCHIMED / 3verestBefore this deal
Deal Web
Every firm and person on this deal, and how they connect. Open any name to see their other deals.
Closed · ARCHIMED acquired Standard BioTools’ Microfluidics Business (Closed, published 3 Nov 2026).
Closed 3 Nov 2026- Closed
- Published by the source
Deal Web as a list
- ARCHIMED (Buyer) acquired this deal. ARCHIMED: 5 deals on Carrywatch.
By email · Weekly